What is the Future of Antiviral Therapies in Cancer Care?
The future of antiviral therapies in cancer care is promising, with ongoing research aimed at developing more effective and targeted treatments. New antiviral drugs with better resistance profiles and fewer side effects are in development. Gene editing technologies like CRISPR hold potential for directly targeting and eliminating oncogenic viruses. Furthermore, personalized medicine approaches are being explored to tailor antiviral therapies to individual patients based on their genetic makeup and the specific characteristics of their viral infections.
